• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤科手术中使用的新型止血剂。

Newer hemostatic agents used in the practice of dermatologic surgery.

作者信息

Henley Jill, Brewer Jerry D

机构信息

College of Osteopathic Medicine Glendale, Midwestern University, 13989 N59th Avenue, Glendale, AZ 85308, USA.

出版信息

Dermatol Res Pract. 2013;2013:279289. doi: 10.1155/2013/279289. Epub 2013 Aug 7.

DOI:10.1155/2013/279289
PMID:23997764
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3749606/
Abstract

Minor postoperative bleeding is the most common complication of cutaneous surgery. Because of the commonality of this complication, hemostasis is an important concept to address when considering dermatologic procedures. Patients that have a bleeding diathesis, an inherited/acquired coagulopathy, or who are on anticoagulant/antiplatelet medications pose a greater risk for bleeding complications during the postoperative period. Knowledge of these conditions preoperatively is of the utmost importance, allowing for proper preparation and prevention. Also, it is important to be aware of the various hemostatic modalities available, including electrocoagulation, which is among the most effective and widely used techniques. Prompt recognition of hematoma formation and knowledge of postoperative wound care can prevent further complications such as wound dehiscence, infection, or skin-graft necrosis, minimizing poor outcomes.

摘要

术后轻微出血是皮肤外科手术最常见的并发症。由于这种并发症很常见,因此在考虑皮肤科手术时,止血是一个需要解决的重要概念。有出血素质、遗传性/获得性凝血病或正在服用抗凝/抗血小板药物的患者在术后发生出血并发症的风险更高。术前了解这些情况至关重要,有助于进行适当的准备和预防。此外,了解各种可用的止血方法也很重要,包括电凝,这是最有效且应用最广泛的技术之一。及时识别血肿形成并掌握术后伤口护理知识可预防进一步的并发症,如伤口裂开、感染或皮肤移植坏死,从而将不良后果降至最低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d783/3749606/0fdde110dd92/DRP2013-279289.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d783/3749606/ab29fc56dd84/DRP2013-279289.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d783/3749606/681284799b88/DRP2013-279289.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d783/3749606/0d6aab9a6c01/DRP2013-279289.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d783/3749606/0fdde110dd92/DRP2013-279289.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d783/3749606/ab29fc56dd84/DRP2013-279289.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d783/3749606/681284799b88/DRP2013-279289.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d783/3749606/0d6aab9a6c01/DRP2013-279289.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d783/3749606/0fdde110dd92/DRP2013-279289.004.jpg

相似文献

1
Newer hemostatic agents used in the practice of dermatologic surgery.皮肤科手术中使用的新型止血剂。
Dermatol Res Pract. 2013;2013:279289. doi: 10.1155/2013/279289. Epub 2013 Aug 7.
2
Prospective evaluation of dermatologic surgery complications including patients on multiple antiplatelet and anticoagulant medications.前瞻性评估皮肤科手术并发症,包括正在服用多种抗血小板和抗凝药物的患者。
J Am Acad Dermatol. 2011 Sep;65(3):576-583. doi: 10.1016/j.jaad.2011.02.012. Epub 2011 Jul 22.
3
Achieving hemostasis in dermatology-Part II: Topical hemostatic agents.皮肤科止血的实现——第二部分:局部止血剂。
Indian Dermatol Online J. 2013 Jul;4(3):172-6. doi: 10.4103/2229-5178.115509.
4
Update and Review of Bleeding Considerations in Dermatologic Surgery: Hemostatic Techniques and Treatment Strategies for Bleeding Complications.皮肤科手术中出血问题的更新与回顾:止血技术和出血并发症的治疗策略。
Dermatol Surg. 2020 Feb;46(2):203-212. doi: 10.1097/DSS.0000000000002138.
5
Mohs Micrographic Surgery: Anticoagulants and Hemostatic Agents Impact莫氏显微外科手术:抗凝剂与止血剂的影响
6
Bleeding on the cutting edge: A systematic review of anticoagulant and antiplatelet continuation in minor cutaneous surgery.前沿出血:小型皮肤手术中抗凝和抗血小板药物持续使用的系统评价
J Plast Reconstr Aesthet Surg. 2018 Apr;71(4):455-467. doi: 10.1016/j.bjps.2017.11.024. Epub 2017 Nov 28.
7
Influence of local hemostatic and antiplatelet agents on the incidence of bleeding complications in carotid endarterectomies.
Clin Hemorheol Microcirc. 2014;58(1):271-9. doi: 10.3233/CH-141901.
8
Anticoagulant complications in facial plastic and reconstructive surgery.面部整形与重建手术中的抗凝并发症
JAMA Facial Plast Surg. 2015 Mar-Apr;17(2):103-7. doi: 10.1001/jamafacial.2014.1147.
9
Retrospective Evaluation of the Safety of Large Skin Flap, Large Skin Graft, and Interpolation Flap Surgery in the Outpatient Setting.门诊环境下大皮瓣、大皮片及插补皮瓣手术安全性的回顾性评估
Dermatol Surg. 2018 Dec;44(12):1537-1546. doi: 10.1097/DSS.0000000000001605.
10
Obtaining rapid and effective hemostasis: Part I. Update and review of topical hemostatic agents.快速有效止血:第一部分。局部止血剂的更新与回顾。
J Am Acad Dermatol. 2013 Nov;69(5):659.e1-659.e17. doi: 10.1016/j.jaad.2013.07.014.

引用本文的文献

1
Biopsy Techniques for Skin Disease and Skin Cancer: A New Approach.皮肤病与皮肤癌的活检技术:一种新方法。
J Cutan Aesthet Surg. 2020 Jul-Sep;13(3):251-254. doi: 10.4103/JCAS.JCAS_173_19.
2
First Safety and Performance Evaluation of T45K, a Self-Assembling Peptide Barrier Hemostatic Device, After Skin Lesion Excision.自组装肽屏障止血装置T45K在皮肤病变切除后的首次安全性和性能评估。
Dermatol Surg. 2018 Jul;44(7):939-948. doi: 10.1097/DSS.0000000000001468.
3
Association of Central Nervous System Depression With Topical Brimonidine When Used for Hemostasis: A Serious Adverse Event.

本文引用的文献

1
Complications of tissue ischemia in dermatologic surgery.皮肤外科组织缺血并发症。
Dermatol Ther. 2011 Nov-Dec;24(6):551-7. doi: 10.1111/j.1529-8019.2012.01459.x.
2
Anticoagulant activity of select dietary supplements.某些膳食补充剂的抗凝活性。
Nutr Rev. 2012 Feb;70(2):107-17. doi: 10.1111/j.1753-4887.2011.00444.x.
3
Achieving hemostasis with topical hemostats: making clinically and economically appropriate decisions in the surgical and trauma settings.使用局部止血剂实现止血:在手术和创伤环境中做出临床和经济上合适的决策。
用于止血时中枢神经系统抑制与局部用溴莫尼定的关联:一种严重不良事件。
JAMA Dermatol. 2017 Jun 1;153(6):575-577. doi: 10.1001/jamadermatol.2017.0247.
AORN J. 2011 Nov;94(5):S1-20. doi: 10.1016/j.aorn.2011.09.018.
4
Fibrin sealant (evicel® [quixil®/crosseal™]): a review of its use as supportive treatment for haemostasis in surgery.纤维蛋白胶(evicel® [quixil®/crosseal™]):作为手术中止血支持治疗的用途概述。
Drugs. 2011 Oct 1;71(14):1893-915. doi: 10.2165/11207700-000000000-00000.
5
Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysis.银杏叶提取物标准化治疗是否存在出血风险?系统评价和荟萃分析。
Pharmacotherapy. 2011 May;31(5):490-502. doi: 10.1592/phco.31.5.490.
6
[Tumescent anesthesia in dermatologic surgery].
Actas Dermosifiliogr. 2012 May;103(4):285-7. doi: 10.1016/j.ad.2011.06.006. Epub 2011 Sep 8.
7
Prospective evaluation of dermatologic surgery complications including patients on multiple antiplatelet and anticoagulant medications.前瞻性评估皮肤科手术并发症,包括正在服用多种抗血小板和抗凝药物的患者。
J Am Acad Dermatol. 2011 Sep;65(3):576-583. doi: 10.1016/j.jaad.2011.02.012. Epub 2011 Jul 22.
8
Complications of cutaneous surgery in patients taking clopidogrel-containing anticoagulation.服用氯吡格雷抗凝药物的患者的皮肤外科手术并发症。
J Am Acad Dermatol. 2011 Sep;65(3):584-591. doi: 10.1016/j.jaad.2011.02.013. Epub 2011 Apr 21.
9
In vitro analysis of polyurethane foam as a topical hemostatic agent.聚氨酯泡沫作为局部止血剂的体外分析。
J Mater Sci Mater Med. 2011 Apr;22(4):1081-6. doi: 10.1007/s10856-011-4276-9. Epub 2011 Mar 19.
10
Omega-3 and fish oil supplements do not cause increased bleeding during spinal decompression surgery.Omega-3和鱼油补充剂不会在脊柱减压手术期间导致出血增加。
J Spinal Disord Tech. 2012 May;25(3):129-32. doi: 10.1097/BSD.0b013e3182120227.